Genecast was established in Beijing in 2014 and is headquartered in the city of Wuxi, Jiangsu Province. It boasts a total of more than 7000㎡ in operating space, with facilities in cities such as Beijing and Taizhou. This includes its CAP-certified precision medicine diagnostic laboratory, which holds a Practice License of Medical Institution, awarded by Wuxi City Health Commission; its precision tumor diagnosis and treatment big data center; and its GMP-compliant IVD reagents manufacturing base.
2019.10
Genecast Biotechnology Receives ¥300 Million in Series D1 Financing
2019.09
Genecast Biotechnology Wins “EY Fudan China the Most Promising Enterprises Award”
2019.09
Genecast Biotechnology Obtains Qualification for NGS Detection
2019.08
AstraZeneca and Genecast Biotechnology Sign Agreement for Strategic Cooperation in Precision Medicine
Genecast was established in Beijing in 2014 and is headquartered in the city of Wuxi, Jiangsu Province. With the second-generation sequencing technology and bioinformatics as the core, the company is engaged in non-invasive and precise diagnosis and diagnosis of tumors, and is committed to becoming a leader in improving the quality of life of cancer patients.With the second-generation sequencing technology and bioinformatics as the core, the company is engaged in non-invasive and precise diagnosis and diagnosis of tumors, and is committed to becoming a leader in improving the quality of life of cancer patients.
We are committed to being improved
the leader in the quality of life of cancer patients.